Literature DB >> 33924745

Prevention and Treatment of Peritoneal Metastases from Gastric Cancer.

Paul H Sugarbaker1.   

Abstract

Common knowledge would suggest that regional treatments for peritoneal metastases from gastric cancer would not be successful [...].

Entities:  

Year:  2021        PMID： 33924745     DOI： 10.3390/jcm10091899

Source DB:  PubMed          Journal:  J Clin Med        ISSN： 2077-0383            Impact factor:   4.241


  6 in total

Review 1.  Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases.

Authors:  Zhong-He Ji; Kai-Wen Peng; Yang Yu; Xin-Bao Li; Yutaka Yonemura; Yang Liu; Paul H Sugarbaker; Yan Li
Journal:  Int J Hyperthermia       Date:  2017-08       Impact factor: 3.914

2.  Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.

Authors:  Irene Thomassen; Yvette R van Gestel; Bert van Ramshorst; Misha D Luyer; Koop Bosscha; Simon W Nienhuijs; Valery E Lemmens; Ignace H de Hingh
Journal:  Int J Cancer       Date:  2013-08-05       Impact factor: 7.396

3.  Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.

Authors:  Pierre-Emmanuel Bonnot; Guillaume Piessen; Vahan Kepenekian; Evelyne Decullier; Marc Pocard; Bernard Meunier; Jean-Marc Bereder; Karine Abboud; Frédéric Marchal; François Quenet; Diane Goere; Simon Msika; Catherine Arvieux; Nicolas Pirro; Romuald Wernert; Patrick Rat; Johan Gagnière; Jeremie H Lefevre; Thomas Courvoisier; Reza Kianmanesh; Delphine Vaudoyer; Michel Rivoire; Pierre Meeus; Guillaume Passot; Olivier Glehen
Journal:  J Clin Oncol       Date:  2019-05-14       Impact factor: 44.544

4.  CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer.

Authors:  T Boerner; A Graichen; T Jeiter; F Zemann; P Renner; L März; Y Soeder; H J Schlitt; P Piso; M H Dahlke
Journal:  Ann Surg Oncol       Date:  2016-06-16       Impact factor: 5.344

5.  Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.

Authors:  Hironori Ishigami; Yoshiyuki Fujiwara; Ryoji Fukushima; Atsushi Nashimoto; Hiroshi Yabusaki; Motohiro Imano; Haruhiko Imamoto; Yasuhiro Kodera; Yoshikazu Uenosono; Kenji Amagai; Shigenori Kadowaki; Hiroto Miwa; Hironori Yamaguchi; Takuhiro Yamaguchi; Tempei Miyaji; Joji Kitayama
Journal:  J Clin Oncol       Date:  2018-05-10       Impact factor: 44.544

6.  Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer.

Authors:  Yutaka Yonemura; Ayman Elnemr; Yoshio Endou; Haruaki Ishibashi; Akiyoshi Mizumoto; Masahiro Miura; Yan Li
Journal:  Int J Surg Oncol       Date:  2012-07-31
  6 in total
  2 in total

Review 1.  Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined with Surgery: A 12-Year Meta-Analysis of this Promising Treatment Strategy for Advanced Gastric Cancer at Different Stages.

Authors:  Jian-Feng Zhang; Ling Lv; Shuai Zhao; Qian Zhou; Cheng-Gang Jiang
Journal:  Ann Surg Oncol       Date:  2022-02-17       Impact factor: 5.344

2.  Efficacy of Traditional Chinese Medicine Combined with Chemotherapy in the Treatment of Gastric Cancer: A Meta-analysis.

Authors:  Wenxin Zhang; Yijuan Zhao; Hongbo Liu; Chunying Jing
Journal:  Comput Math Methods Med       Date:  2022-08-04       Impact factor: 2.809
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.